Management of Rare Ovarian Cancer Histologies-Reference-Cited by-同舟云学术

Management of Rare Ovarian Cancer Histologies

Published:2019-09-20 Issue:27 Volume:37 Page:2406-2415
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Gershenson David M.¹,Okamoto Aikou²,Ray-Coquard Isabelle³

Affiliation:

1. The University of Texas MD Anderson Cancer Center, Houston, TX

2. The Jikei University School of Medicine, Tokyo, Japan

3. Centre Leon Bèrard, Université Claude Bernard Lyon, Groupe d’Investigateurs Nationaux pour l’Étude des Cancers de l’Ovaire (GINECO), Lyon, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.18.02419

Reference76 articles.

1. Rare cancers are not so rare: The rare cancer burden in Europe

2. Networking for ovarian rare tumors: a significant breakthrough improving disease management

3. Kurman RJ, Carcangiu ML, Herrington S, et al (eds): WHO Classification of Tumours of Female Reproductive Organs (ed 4). Lyon, France, International Agency for Research on Cancer, 2014

4. Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors

5. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer Therapy;Advances in Experimental Medicine and Biology;2024

2. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC);Pleura and Peritoneum;2023-12-27

3. Comprehensive Review of Serous Tumors of Tubo-Ovarian Origin: Clinical Behavior, Pathological Correlation, Current Molecular Updates, and Imaging Manifestations;Current Problems in Diagnostic Radiology;2023-09

4. Avancées thérapeutiques dans la prise en charge des tumeurs rares malignes ovariennes;Bulletin du Cancer;2023-07

5. Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study;Gynecologic Oncology;2023-07